Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction

PHASE4TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Post-Traumatic Headache
Interventions
DRUG

sumatriptan/naproxen sodium

Each tablet of Treximet for oral administration contains sumatriptan 85mg / naproxen sodium 500mg. Study medication is to be administered 1 tablet per day at the same time each day x 30 days in the Treatment Period.

DRUG

Placebo

Each tablet of placebo for oral administration matches Treximet. Placebo is to be administered 1 tablet per day at the same time each day x 30 days in the Treatment Period.

Trial Locations (3)

37203

Nashville Neuroscience Group, PC, Nashville

65807

Clinvest, Springfield

76508

Scott & White Memorial Hospital and Clinic, Temple

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Cady, Roger, M.D.

INDIV